Literature DB >> 28842060

After 4 Decades of Lupus Nephritis Trials, Is There a "Best" Therapy?

Andrew S Bomback1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28842060      PMCID： PMC5901645          DOI： 10.1053/j.ajkd.2017.05.016

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  11 in total

1.  Outcomes in African Americans and Hispanics with lupus nephritis.

Authors:  G Contreras; O Lenz; V Pardo; E Borja; C Cely; K Iqbal; N Nahar; C de La Cuesta; A Hurtado; A Fornoni; L Beltran-Garcia; A Asif; L Young; J Diego; M Zachariah; B Smith-Norwood
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

2.  The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients.

Authors:  A S Alvarado; A Malvar; B Lococo; V Alberton; F Toniolo; H N Nagaraja; B H Rovin
Journal:  Lupus       Date:  2014-01-08       Impact factor: 2.911

Review 3.  Updates on the treatment of lupus nephritis.

Authors:  Andrew S Bomback; Gerald B Appel
Journal:  J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 10.121

4.  Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.

Authors:  Zhihong Liu; Haitao Zhang; Zhangsuo Liu; Changying Xing; Ping Fu; Zhaohui Ni; Jianghua Chen; Hongli Lin; Fuyou Liu; Yongcheng He; Yani He; Lining Miao; Nan Chen; Ying Li; Yong Gu; Wei Shi; Weixin Hu; Zhengzhao Liu; Hao Bao; Caihong Zeng; Minlin Zhou
Journal:  Ann Intern Med       Date:  2015-01-06       Impact factor: 25.391

5.  Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995.

Authors:  M M Ward
Journal:  Arch Intern Med       Date:  2000-11-13

6.  Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.

Authors:  M F Gourley; H A Austin; D Scott; C H Yarboro; E M Vaughan; J Muir; D T Boumpas; J H Klippel; J E Balow; A D Steinberg
Journal:  Ann Intern Med       Date:  1996-10-01       Impact factor: 25.391

7.  Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.

Authors:  Frédéric A Houssiau; Carlos Vasconcelos; David D'Cruz; Gian Domenico Sebastiani; Enrique de Ramon Garrido Ed; Maria Giovanna Danieli; Daniel Abramovicz; Daniel Blockmans; Alessandro Mathieu; Haner Direskeneli; Mauro Galeazzi; Ahmet Gül; Yair Levy; Peter Petera; Rajko Popovic; Radmila Petrovic; Renato Alberto Sinico; Roberto Cattaneo; Josep Font; Geneviève Depresseux; Jean-Pierre Cosyns; Ricard Cervera
Journal:  Arthritis Rheum       Date:  2002-08

8.  Successful treatment of class V+IV lupus nephritis with multitarget therapy.

Authors:  Hao Bao; Zhi-Hong Liu; Hong-Lang Xie; Wei-Xin Hu; Hai-Tao Zhang; Lei-Shi Li
Journal:  J Am Soc Nephrol       Date:  2008-07-02       Impact factor: 10.121

9.  Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004.

Authors:  Michael M Ward
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

10.  Histologic versus clinical remission in proliferative lupus nephritis.

Authors:  Ana Malvar; Paola Pirruccio; Valeria Alberton; Bruno Lococo; Cecilia Recalde; Bernanda Fazini; Haikady Nagaraja; Divya Indrakanti; Brad H Rovin
Journal:  Nephrol Dial Transplant       Date:  2017-08-01       Impact factor: 5.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.